EPISODE · Mar 6, 2025 · 0 MIN
今日肿瘤学最高分文献 - 2025-03-06
from 萌喵读文献-肿瘤学 · host Meng Zhao
欢迎收听最新一期的医学突破播客！今天，我们将聚焦2024年小细胞肺癌（SCLC）治疗领域的重大进展。这项研究为我们带来了希望，特别是在免疫疗法领域，通过durvalumab、tarlatamab和lurbinectedin等新疗法，患者的生存期得到了显著延长，有望实现长期生存。此外，精准医学的应用和生物标志物选择的可行性也在推动SCLC治疗的个性化。最后，新成立的倡导团体Small Cell SMASHERS为患者提供了更多支持。这标志着SCLC治疗革命的到来，开启了对抗这一致命疾病的新时代。不要错过，让我们一起探索这些激动人心的发现！
Embed this episode
NOW PLAYING
今日肿瘤学最高分文献 - 2025-03-06
0:00
0:04
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 萌喵读文献-肿瘤学?
This episode is 0 minutes long.
When was this 萌喵读文献-肿瘤学 episode published?
This episode was published on March 6, 2025.
Can I download this 萌喵读文献-肿瘤学 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!